REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION

Administration Should Abandon Misguided Policy That Rewards Drug Companies’ Price-Gouging and Anti-Competitive Tactics With Massive Bailout On Monday, the Trump Administration took a step toward

11-16-2020 Read More

CSRXP: COVID-19 TREATMENTS AND VACCINES MUST BE ACCESSIBLE AND AFFORDABLE FOR ALL AMERICANS

Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to Affordable Pricing For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign

11-9-2020 Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA & BRISTOL-MYERS SQUIBB

Big Pharma Completes Sweep of Beating Wall Street Expectations After 2020 Price Hikes In a final round of third quarter earnings reports, three more Big Pharma giants announced they surpassed

11-5-2020 Read More

BIG PHARMA EARNINGS WATCH: AMGEN & SANOFI

Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants Amgen and Sanofi topped earnings expectations while continuing to hike prices, according to third-quarter earnings

11-5-2020 Read More

CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP

Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir After Setting Price More Than 13 Times Cost of Production For Immediate Release Contact: Jon Conradi 860-235-3884

10-30-2020 Read More

SECOND OPINION: BIG PHARMA GAMES THE PATENT SYSTEM TO HIKE PRICES AND BOOST PROFITS — NOT ‘DRIVE INNOVATION’ OR ‘ENHANCE PATIENT ACCESS’

Drug Companies’ Anti-Competitive Gamesmanship Comes At Tremendous Cost To U.S. Health Care System And Contributes To Out-of-Control Prescription Drug Prices Following a hearing earlier this month

10-29-2020 Read More

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE

Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices A new third quarter earnings report released today from Big Pharma giant GlaxoSmithKline (GSK) demonstrates yet again that

10-29-2020 Read More

BIG PHARMA EARNINGS WATCH: MERCK, NOVARTIS & PFIZER

Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly Hiking Prices New earnings reports for the third quarter of 2020 show that Big Pharma giants are continuing to rake in

10-28-2020 Read More

ICYMI: BIG PHARMA’S PANDEMIC PRICE HIKES AND PATENT ABUSE UNDERSCORE URGENCY FOR ACTION

Big Pharma’s Pandemic Price Hikes and Patent Abuse Underscore Urgency for Action By Lauren Aronson Morning Consult October 28, 2020 https://morningconsult.

10-28-2020 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.